Esperion (ESPR) announced that following meetings with the U.S. Food and Drug Administration, it has gained alignment on a regulatory path ...

I am 71, and I recently saw my urologist for urinating a lot and not getting enough sleep. He performed a flow test and a ...

Merck Data at ACC.25 Highlight Innovative Advancements and Commitment to Improving Outcomes for People Living with Cardiovascular Disease ...

After hours: March 19 at 4:38:17 PM EDT Loading Chart for NAMS ...

In OCEAN(a)-DOSE, most patients were already on other therapies, including statins, PCSK9 drugs, and cholesterol absorption inhibitor ezetimibe. "Epidemiological research has shown us that Lp(a ...

Shares of NewAmsterdam Pharma (NASDAQ:NAMS – Get Free Report) have been given an average rating of “Buy” by the six analysts ...

Our Bureau, Mumbai Tuesday, March 18, 2025, 16:30 Hrs [IST] ...

Yet another suit alleges an ERISA fiduciary breach regarding the administration of a corporate healthcare plan.

although there is no data directly comparing the drug with other treatments like Organon's Ezetrol (ezetimibe) and PCSK9 antibodies Praluent (alirocumab) from Sanofi/Regeneron and Amgen's Repatha ...

a fixed-dose combination tablet of bempedoic acid and ezetimibe to reduce cholesterol; and Efient, an anti-platelet agent. In addition, the company offers Canalia and Tenelia for the treatment of ...